19-Noraldosterone in pregnancy-induced hypertension

Steroids

Volumn 67, Issue 7, 2002, Pages 605-610

  Takeda, Yoshiyu ^a   Yoneda, Takashi ^a   Demura, Masashi ^a   Furukawa, Kenji ^a   Usukura, Mikiya ^a   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

19 Noraldosterone; Hypertension; Mineralocorticoid; Pregnancy; Receptor; Steroids

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 19 NORALDOSTERONE; ALDOSTERONE DERIVATIVE; CORTICOSTEROID RECEPTOR; CORTISONE; HYDROCORTISONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HORMONE URINE LEVEL; HUMAN; MATERNAL HYPERTENSION; MONOCYTE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SEQUENCE ANALYSIS; URINALYSIS;

ADOLESCENT; ADULT; ALDOSTERONE; FEMALE; HUMANS; MINERALOCORTICOIDS; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, MINERALOCORTICOID;

EID: 0036241431     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(02)00009-0     Document Type: Article

References (41)

1. Current concepts: Hypertension in pregnancy
2. A role of prostaglandins in hypertension
3. Mineralocorticoid effector mechanism in preeclampsia
4. Aldosterone receptors in different types of primary aldosteronism
5. 11β-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy
6. Plasma deoxycorticosterone in normal and abnormal human pregnancy
7. Synthesis of 19-noraldosterone, 18-hydroxy-19-norcorticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma
8. 19-Noraldosterone, a new mineralocorticoid
9. The effects of 19-noraldosterone on blood pressure of adrenalectomized rats
10. 5-aldosterone: Relative potencies measured in two bioassay systems
11. Effect of adrenocorticotropin stimulation on the synthesis of 19-noraldosterone in man
12. Urinary excretion of 19-noraldosterone, 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism
13. Urinary excretion of 19-noraldosterone in the spontaneously hypertensive rat and stroke-prone spontaneously hypertensive rat
14. Studies on steroid conjugates: Quantitative paper chromatography of urinary corticosteroids in essential hypertension
15. Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension
16. Gene expression of 11β-hydroxysteroid dehydrogenase in the mesenteric arteries of genetically hypertensive rats
17. Several homozygous mutations in the gene for 11β-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess
18. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase
19. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
20. The classification and definition of the hypertensive disorders of pregnancy
21. Blood-pressure measurement and classification in pregnancy
22. Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism
23. Endogenous renal 11β-hydroxysteroid dehydrogenase inhibitory factors in patients with low-renin essential hypertension
24. Mineralocorticoids and mineralocorticoid receptors in mononuclear leukocytes in patients with pregnancy-induced hypertension
25. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I
26. Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease of pregnancy
27. Impaired cortisol binding to glucocorticoid receptors in hypertensive patients
28. Hypertension in pregnancy
29. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone
30. Urinary 19-nor-deoxycorticosterone and deoxycorticosterone and deoxycorticosterone in hypertensive disease of pregnancy
31. Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in subjects with untreated essential hypertension
32. Renal 11β-hydroxysteroid dehydrogenase in genetically salt-sensitive hypertensive rats
33. Molecular basis of human salt sensitivity: The role of the 11β-hydroxysteroid dehydrogenase type 2
34. Progesterone metabolism in the human kidney and inhibition of 11β-hydroxysteroid dehydrogenase type 2 by progesterone and metabolites
35. Cure of apparent mineralocorticoid excess by kidney transplantation
36. Placental 11β-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic pregnancies
37. Decreased gene expression of 11β-hydroxysteroid dehydrogenase type2 and 16-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia
38. Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy
39. Alteration of the adrenomedullin receptor components gene expression associated with the blood pressure in pregnancy-induced hypertension
40. Serum allopregnanolone levels in pregnant women: Changes during pregnancy, at delivery, and in hypertensive patients
41. Mechanism of action of the potent sodium-retaining steroid 11,19-oxidoprogesterone